Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura.
Johanna A. Kremer Hovinga(University of Bern), Bernhard Lämmle(Johannes Gutenberg University Mainz), Max Solenthaler(University Hospital of Bern), Franziska Demarmels Biasiutti(University Hospital of Bern), Behrouz Mansouri Taleghani(University of Bern), Andreas Tobler(University Hospital of Bern), Caroline Zwicky, Lorenzo Alberio(University of Lausanne), Jan–Dirk Studt(University of Zurich), Stefano Fontana
PubMed
March 1, 2004
Cited by 66
Related Papers
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
|New England Journal of Medicine|1998|1.7k
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia
|Blood|2007|168
Thrombotic Risk of Women with Hereditary Antithrombin III-, Protein C- and Protein S-Deficiency Taking Oral Contraceptive Medication
|Thrombosis and Haemostasis|1994|107
Patient blood management (PBM) in pregnancy and childbirth: literature review and expert opinion
|Archives of Gynecology and Obstetrics|2019|96
Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia
|The American Journal of Medicine|2003|72